Circ_0016760 accelerates non‐small‐cell lung cancer progression through miR‐646/AKT3 signaling in vivo and in vitro

por Shan Chen, Long Zhou, Ruizhi Ran, Jinqi Huang, Yong Zheng, Maohui Xing, Yanli Cai
Publicado 2021

Identification of Prognostic Gene Biomarkers in Non-Small Cell Lung Cancer Progression by Integrated Bioinformatics Analysis

por Panagiotis Giannos, Konstantinos S. Kechagias, Annamaria Gal
Publicado 2021

Stereotactic body radiation therapy (SBRT) in the management of non-small-cell lung cancer: Clinical impact and patient perspectives

por Donovan EK, Swaminath A
Publicado 2018

A retrospective study of clinicopathologic and molecular features of inoperable early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy

por I-Han Lee, Guann-Yiing Chen, Chun-Ru Chien, Jason Chia-Hsien Cheng, Jenny Ling-Yu Chen, Wen-Chi Yang, Jin-Shing Chen, Feng-Ming Hsu
Publicado 2021

Antiangiogenic therapy in pretreated patients with lung adenocarcinoma without activating mutations: new features

por Elena V. Reutova, Konstantin K. Laktionov
Publicado 2021

Adjuvant targeted therapy for non-small cell lung cancer

por Konstantin K. Laktionov, Aleksei M. Kazakov, Marat G. Gordiev, Pavel V. Kononets, Bakhrom B. Akhmedov, Julia N. Maevskaia
Publicado 2020

Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib

por Tan AC, Loh TJ, Kwang XL, Tan GS, Lim KH, Tan DSW
Publicado 2021

Targeting HER2 genomic alterations in non-small cell lung cancer

por Jie Zeng, Weijie Ma, Richard Benjamin Young, Tianhong Li
Publicado 2021

Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers

por Stratmann JA, Sebastian M
Publicado 2019

Real-World Approach for Molecular Analysis of Acquired EGFR Tyrosine Kinase Inhibitor Resistance Mechanisms in NSCLC

por Liesbeth M. Hondelink, MD, Merel Jebbink, MD, Jan H. von der Thüsen, MD, PhD, Danielle Cohen, MD, PhD, Hendrikus J. Dubbink, PhD, Marthe S. Paats, MD, PhD, Anne-Marie C. Dingemans, MD, PhD, Adrianus J. de Langen, MD, PhD, Mirjam C. Boelens, PhD, Egbert F. Smit, MD, PhD, Pieter E. Postmus, MD, PhD, Tom van Wezel, PhD, Kim Monkhorst, MD, PhD
Publicado 2021

Predictive Risk Factors for Early Recurrence of Stage pIIIA-N2 Non-Small Cell Lung Cancer

por Yu Q, Du X, Fang Z, Mao X, Wu J, Wang B, Li W
Publicado 2021

Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics

por Guo MZ, Marrone KA, Spira A, Waterhouse DM, Scott SC
Publicado 2021

MicroRNA-326 impairs chemotherapy resistance in non small cell lung cancer by suppressing histone deacetylase SIRT1-mediated HIF1α and elevating VEGFA: Roles of miR-326 in chemores...

por Jinying Wei, Guangping Meng, Jing Wu, Ying Wang, Qiang Zhang, Ting Dong, Jin Bao, Chunyan Wang, Jie Zhang
Publicado 2021

Circular RNA SOX13 promotes malignant behavior and cisplatin resistance in non-small cell lung cancer through targeting microRNA-3194-3p/microtubule-associated protein RP/EB family...

por Libin Zhang, Hao Peng, Zheyuan Xu, Qiuju Yang, Yang Wang, Han Wang, Liang Bu
Publicado 2021

PPy@Fe3O4 Nanoparticles Inhibit Tumor Growth and Metastasis Through Chemodynamic and Photothermal Therapy in Non-small Cell Lung Cancer

por Danruo Fang, Hansong Jin, Xiulin Huang, Yongxin Shi, Zeyu Liu, Suqin Ben
Publicado 2021

Single-Cell RNA Sequencing Reveals the Heterogeneity of Tumor-Associated Macrophage in Non-Small Cell Lung Cancer and Differences Between Sexes

por Qi Yang, Hongman Zhang, Ting Wei, Anqi Lin, Yueqin Sun, Peng Luo, Jian Zhang
Publicado 2021

MTA1 Expression Can Stratify the Risk of Patients with Multifocal Non-Small Cell Lung Cancers ≤3 cm

por Wang W, Hu Z, Ma M, Yin H, Huang Y, Zhao G, Cui X, Sun Q, Yang Y, Yang Y, Wang B, Ye L
Publicado 2021

CircMMP11 overexpression predicts the poor survival of non-small cell lung cancer and downregulates miR-143 through methylation to suppress cell proliferation

por Juan Chen, Jiang Gong
Publicado 2021

BHLHE41/DEC2 Expression Induces Autophagic Cell Death in Lung Cancer Cells and Is Associated with Favorable Prognosis for Patients with Lung Adenocarcinoma

por Toshiyuki Nagata, Kentaro Minami, Masatatsu Yamamoto, Tsubasa Hiraki, Masashi Idogawa, Katsumi Fujimoto, Shun Kageyama, Kazuhiro Tabata, Kohichi Kawahara, Kazuhiro Ueda, Ryuji Ikeda, Yukio Kato, Masaaki Komatsu, Akihide Tanimoto, Tatsuhiko Furukawa, Masami Sato
Publicado 2021

Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature

por Michela Verzè, Roberta Minari, Letizia Gnetti, Paola Bordi, Alessandro Leonetti, Agnese Cosenza, Leonarda Ferri, Maria Majori, Massimo De Filippo, Sebastiano Buti, Donatello Gasparro, Rita Nizzoli, Cinzia Azzoni, Lorena Bottarelli, Anna Squadrilli, Paola Mozzoni, Marcello Tiseo
Publicado 2021